Karamanou K - Search Results

1

Biological function of unique sulfated glycosaminoglycans in primitive chordates.

Karamanou K, Espinosa DCR, Fortuna-Costa A, Pavão MSG. Karamanou K, et al. Glycoconj J. 2017 Jun;34(3):277-283. doi: 10.1007/s10719-016-9728-5. Epub 2016 Sep 10. Glycoconj J. 2017. PMID: 27614617 Review.

2

The role of heparins and nano-heparins as therapeutic tool in breast cancer.

Afratis NA, Karamanou K, Piperigkou Z, Vynios DH, Theocharis AD. Afratis NA, et al. Among authors: karamanou k. Glycoconj J. 2017 Jun;34(3):299-307. doi: 10.1007/s10719-016-9742-7. Epub 2016 Oct 24. Glycoconj J. 2017. PMID: 27778131 Review.

3

Biochemical and toxicological evaluation of nano-heparins in cell functional properties, proteasome activation and expression of key matrix molecules.

Piperigkou Z, Karamanou K, Afratis NA, Bouris P, Gialeli C, Belmiro CL, Pavão MS, Vynios DH, Tsatsakis AM. Piperigkou Z, et al. Among authors: karamanou k. Toxicol Lett. 2016 Jan 5;240(1):32-42. doi: 10.1016/j.toxlet.2015.10.005. Epub 2015 Oct 22. Toxicol Lett. 2016. PMID: 26476401

4

Estrogen receptor alpha mediates epithelial to mesenchymal transition, expression of specific matrix effectors and functional properties of breast cancer cells.

Bouris P, Skandalis SS, Piperigkou Z, Afratis N, Karamanou K, Aletras AJ, Moustakas A, Theocharis AD, Karamanos NK. Bouris P, et al. Among authors: karamanou k. Matrix Biol. 2015 Apr;43:42-60. doi: 10.1016/j.matbio.2015.02.008. Epub 2015 Feb 27. Matrix Biol. 2015. PMID: 25728938 Free article.

5

Lumican effectively regulates the estrogen receptors-associated functional properties of breast cancer cells, expression of matrix effectors and epithelial-to-mesenchymal transition.

Karamanou K, Franchi M, Piperigkou Z, Perreau C, Maquart FX, Vynios DH, Brézillon S. Karamanou K, et al. Sci Rep. 2017 Mar 23;7:45138. doi: 10.1038/srep45138. Sci Rep. 2017. PMID: 28332606 Free PMC article.

6

Strategies to Target Matrix Metalloproteinases as Therapeutic Approach in Cancer.

Piperigkou Z, Manou D, Karamanou K, Theocharis AD. Piperigkou Z, et al. Among authors: karamanou k. Methods Mol Biol. 2018;1731:325-348. doi: 10.1007/978-1-4939-7595-2_27. Methods Mol Biol. 2018. PMID: 29318564 Review.

7

Epithelial-to-mesenchymal transition and invadopodia markers in breast cancer: Lumican a key regulator.

Karamanou K, Franchi M, Vynios D, Brézillon S. Karamanou K, et al. Semin Cancer Biol. 2020 May;62:125-133. doi: 10.1016/j.semcancer.2019.08.003. Epub 2019 Aug 8. Semin Cancer Biol. 2020. PMID: 31401293 Review.

8

Evaluation of lumican effects on morphology of invading breast cancer cells, expression of integrins and downstream signaling.

Karamanou K, Franchi M, Onisto M, Passi A, Vynios DH, Brézillon S. Karamanou K, et al. FEBS J. 2020 Nov;287(22):4862-4880. doi: 10.1111/febs.15289. Epub 2020 Mar 31. FEBS J. 2020. PMID: 32160387 Free article.

9

Lumican Inhibits In Vivo Melanoma Metastasis by Altering Matrix-Effectors and Invadopodia Markers.

Karamanou K, Franchi M, Proult I, Rivet R, Vynios D, Brézillon S. Karamanou K, et al. Cells. 2021 Apr 8;10(4):841. doi: 10.3390/cells10040841. Cells. 2021. PMID: 33917849 Free PMC article.

10

Emerging aspects of nanotoxicology in health and disease: From agriculture and food sector to cancer therapeutics.

Piperigkou Z, Karamanou K, Engin AB, Gialeli C, Docea AO, Vynios DH, Pavão MS, Golokhvast KS, Shtilman MI, Argiris A, Shishatskaya E, Tsatsakis AM. Piperigkou Z, et al. Among authors: karamanou k. Food Chem Toxicol. 2016 May;91:42-57. doi: 10.1016/j.fct.2016.03.003. Epub 2016 Mar 8. Food Chem Toxicol. 2016. PMID: 26969113 Free article. Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

19 results

Search Page

Filters